Samsung Bioepis Joins Biosimilar Lucentis Fray As It Unveils Phase III Plans

 
• By Jung Won Shin
  
Samsung Bioepis
Samsung Bioepis Headquarters in South Korea • Source: Samsung Bioepis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip